Biopharmaceutical Financialization and Public Funding of Medical Countermeasures (MCMs) in Canada During the COVID-19 PandemicINTERNATIONAL JOURNAL OF HEALTH POLICY AND MANAGEMENTIF5.12023-05-271OAAI